Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,690 | 49,751 | 57,734 | 66,634 | 56,561 |
| TOTAL | $45,054 | $52,131 | $60,162 | $68,686 | $59,055 |
| Non-Current Assets | |||||
| PPE Net | 142 | 148 | 153 | 129 | 134 |
| Other Non-Current Assets | 162 | 172 | 182 | 191 | 201 |
| TOTAL | $304 | $319 | $335 | $321 | $335 |
| Total Assets | $45,359 | $52,451 | $60,496 | $69,006 | $59,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,685 | 1,301 | 3,253 | 6,001 | 6,983 |
| Accrued Expenses | 2,841 | 4,480 | 1,947 | 1,714 | 2,425 |
| TOTAL | $17,087 | $18,340 | $15,675 | $15,064 | $13,630 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,205 | 12,032 | 13,810 | 16,651 | 19,506 |
| TOTAL | $9,267 | $12,110 | $13,903 | $16,760 | $19,629 |
| Total Liabilities | $26,354 | $30,450 | $29,578 | $31,823 | $33,259 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,396 | 37,409 | 36,820 | 36,679 | 36,679 |
| Common Shares | 13 | 12 | 12 | 12 | 11 |
| Retained earnings | -182,111 | -174,159 | -163,432 | -155,104 | -144,501 |
| TOTAL | $19,005 | $22,001 | $30,918 | $37,183 | $26,131 |
| Total Liabilities And Equity | $45,359 | $52,451 | $60,496 | $69,006 | $59,390 |